查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1649446

血管成形術用氣球市場：預測（2025-2030）

Angioplasty Balloons Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

血管成形術用氣球市場預計將從 2025 年的 28.85 億美元成長到 2030 年的 36.02 億美元，預測期內的複合年成長率為 4.54%。

球囊血管成形術是一種用於打通狹窄或阻塞動脈的手術，被認為是一種微創手術。微創手術的成長對整個血管成形術用氣球市場的擴張做出了巨大貢獻。由於老齡化人口中心血管疾病 (CVD) 發病率上升以及生活方式相關風​​險因素增加，市場正在經歷成長。心血管疾病是全球最大的死亡原因，良好的法規環境進一步推動血管成形術用氣球市場的成長。此外，該領域不斷湧現創新產品開發與應用。例如，歐盟統計局報告稱，2022 年進行了 106 萬例腔內冠狀動脈成形術，成為歐洲心血管疾病患者的常見治療方法。

血管成形術用氣球市場促進因素：

  • 心血管疾病發生率不斷上升：心臟病發作時通常使用血管成形術來清除阻塞並恢復血流。具體來說，球囊血管成形術是一種利用球囊治療心血管疾病的微創技術。每年心血管疾病奪走2,050多萬人的生命，其中85%是由於心臟疾病（如心臟病）和腦血管疾病（如中風）。常見的風險因素包括吸煙、糖尿病、高膽固醇、不良飲食和高血壓，在中低收入國家尤其常見。根據世界心臟日預測，到2023年，全球將有約6.2億人患有心臟和循環系統疾病，每年新增病例約6,000萬例。

血管成形術用氣球市場的地理展望：

  • 亞太地區的快速成長：北美市場由於其先進的醫療保健系統、對心血管護理的強勁需求以及冠狀動脈疾病 (CAD) 和周邊動脈疾病(PAD) 發病率的上升而成長。這種需求主要由美國人口老化所推動，這大大增加了心血管疾病的可能性，而這種疾病需要透過血管成形術來清除阻塞的動脈。此外，技術的進步也促進了更複雜的球囊和導管的開發，從而提高了性能。

預計預測期內亞太地區將快速成長。印度和中國等國家由於人口成長和對醫療保健基礎設施的日益重視，對血管成形術用氣球的需求很高。總之，由於心血管疾病盛行率不斷上升、醫療技術的進步以及各地區支持性的法規環境，血管成形術用氣球市場預計將以顯著的速度成長。隨著醫療保健提供者尋求治療心血管疾病的有效解決方案，對微創手術的需求持續增加。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 細分和區域分析，包括收益成長和預測國家
  • 公司概況（策略、產品、財務、主要發展等）

血管成形術用氣球市場細分如下：

按類型

  • 普通氣球
  • 藥物釋放型球囊
  • 球囊導管
  • 非順應性球囊
  • 其他

按應用

  • 周邊設備
  • 冠狀動脈

按最終用戶產業

  • ASC
  • 醫院
  • 導管室

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 其他
  • 中東和非洲
  • UAE
  • 以色列
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 韓國
  • 印度
  • 印尼
  • 台灣
  • 泰國
  • 其他

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第 5 章血管成形術用氣球市場（按類型）

  • 介紹
  • 普通氣球
  • 藥物釋放型球囊
  • 球囊導管
  • 不合規球囊
  • 其他

第6章血管成形術用氣球市場（依應用）

  • 介紹
  • 周邊設備
  • 冠狀動脈

第 7 章血管成形術用氣球市場（依最終用戶分類）

  • 介紹
  • ASCs
  • 醫院
  • 導管室

第 8 章血管成形術用氣球市場（按地區）

  • 介紹
  • 北美洲
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 南美洲
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 歐洲
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 中東和非洲
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 亞太地區
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Infinity Angioplasty Balloon
  • Poba Medical
  • Boston Scientific
  • Philips
  • Concept Medical
  • Lepu Medical Technology Company
  • Terumo Interventional Systems
  • B. Braun
  • Medtronic
  • Conic Vascular
  • Abbott Laboratories.
  • AngioDynamics.
  • Becton
  • Dickinson and Company.
簡介目錄
Product Code: KSI061616263

The angioplasty balloons market is projected to grow at a CAGR of 4.54% over the forecast period, increasing from US$2.885 billion in 2025 to US$3.602 billion by 2030.

Balloon angioplasty is a procedure used to open narrowed or blocked arteries and is considered a minimally invasive surgery. The growth of minimally invasive procedures is significantly contributing to the overall expansion of the angioplasty balloons market. This market is witnessing growth due to the rising incidence of cardiovascular diseases (CVDs) among the aging population and increasing lifestyle-related risk factors. CVDs are the leading cause of death globally, and a favorable regulatory environment further supports the growth of the angioplasty balloons market. Additionally, innovative product developments and applications are emerging within this sector. For instance, Eurostat reported that there were 1.06 million transluminal coronary angioplasty procedures performed in 2022, making it a common intervention for patients with cardiovascular diseases in Europe.

Drivers of the Angioplasty Balloons Market:

  • Increasing Prevalence of Cardiovascular Diseases: Angioplasty is often used during heart attacks to clear blockages and restore blood flow. Balloon angioplasty, specifically, is a minimally invasive technique that utilizes a balloon to treat cardiovascular diseases. Each year, cardiovascular disease claims over 20.5 million lives, with 85% of these deaths attributed to coronary heart diseases (such as heart attacks) and cerebrovascular diseases (such as strokes). Common risk factors include smoking, diabetes, high cholesterol, poor diet, and hypertension, particularly prevalent in low- and middle-income countries. According to World Heart Day, around 620 million people globally were living with heart and circulatory diseases in 2023, with approximately 60 million new cases developing annually.

Geographical Outlook of the Angioplasty Balloons Market:

  • Exponential Growth in Asia Pacific: The North American market is experiencing growth due to its advanced healthcare system, strong demand for cardiovascular procedures, and increasing rates of coronary artery disease (CAD) and peripheral artery disease (PAD). This demand is largely driven by an aging population in the United States, where age significantly increases the likelihood of developing cardiovascular conditions that require angioplasty for clearing blocked arteries. Additionally, technological advancements have led to the development of more sophisticated balloons and catheters that enhance performance.

The Asia Pacific region is anticipated to witness rapid growth during the forecast period. Countries like India and China are experiencing significant demand for angioplasty balloons due to their growing populations and increasing focus on healthcare infrastructure. The rise in lifestyle-related health issues is also contributing to this trend.In summary, the angioplasty balloons market is poised for substantial growth driven by the increasing prevalence of cardiovascular diseases, advancements in medical technology, and supportive regulatory environments across various regions. The demand for minimally invasive procedures continues to rise as healthcare providers seek effective solutions for treating cardiovascular conditions.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Angioplasty Balloons Market has been segmented as following:

By Type

  • Normal Balloons
  • Drug-Eluting Balloons
  • Scoring Balloons
  • Non-Compliant Balloons
  • Others

By Application

  • Peripheral
  • Coronary

By End-User Industry

  • ASCs
  • Hospitals
  • Cath Labs

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Taiwan
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ANGIOPLASTY BALLOONS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Normal Balloons
  • 5.3. Drug-Eluting Balloons
  • 5.4. Scoring Balloons
  • 5.5. Non-Compliant Balloons
  • 5.6. Others

6. ANGIOPLASTY BALLOONS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Peripheral
  • 6.3. Coronary

7. ANGIOPLASTY BALLOONS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. ASCs
  • 7.3. Hospitals
  • 7.4. Cath Labs

8. ANGIOPLASTY BALLOONS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. UK
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Israel
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. India
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Taiwan
      • 8.6.4.7. Thailand
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Infinity Angioplasty Balloon
  • 10.2. Poba Medical
  • 10.3. Boston Scientific
  • 10.4. Philips
  • 10.5. Concept Medical
  • 10.6. Lepu Medical Technology Company
  • 10.7. Terumo Interventional Systems
  • 10.8. B. Braun
  • 10.9. Medtronic
  • 10.10. Conic Vascular
  • 10.11. Abbott Laboratories.
  • 10.12. AngioDynamics.
  • 10.13. Becton
  • 10.14. Dickinson and Company.